Lifecome Biochemistry Co Ltd
002868
Company Profile
Business description
Lifecome Biochemistry Co Ltd is a biopharmaceutical company which is engaged in the microbial pharmacy in China. Its main products include Bacitracin Zinc products (Bacitracin Zinc Premix, Bacitracin Zinc API), Colistin Sulfate products (Colistin Sulfate Premix, Colistin Sulfate API), Probiotics products (Bacillus Subtilis, Bacillus Licheniformis), Bacitracin Methylene Disalicylate products, biological preservatives: and Natamycin products.
Contact
No.19, Nanpu Ecological Industrial Park
Pucheng
Fujian353400
CHNT: +86 5992827451
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
898
Stocks News & Analysis
stocks
Record production for Woodside
Our fair value is updated as progress is made on new development projects.
stocks
Meta earnings: Strong end to 2025 as AI monetization begins to show
Investors please with latest results.
stocks
Why doesn’t the market like the earnings from this US tech giant?
Good quarter with AI demand ramping.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,117.50 | 6.50 | 0.07% |
| CAC 40 | 8,126.53 | 55.17 | 0.68% |
| DAX 40 | 24,538.81 | 229.35 | 0.94% |
| Dow JONES (US) | 48,892.47 | 179.09 | -0.36% |
| FTSE 100 | 10,223.54 | 51.78 | 0.51% |
| HKSE | 27,387.11 | 580.98 | -2.08% |
| NASDAQ | 23,461.82 | 223.30 | -0.94% |
| Nikkei 225 | 53,691.46 | 368.61 | 0.69% |
| NZX 50 Index | 13,410.38 | 12.80 | -0.10% |
| S&P 500 | 6,939.03 | 29.98 | -0.43% |
| S&P/ASX 200 | 8,828.10 | 7.00 | 0.08% |
| SSE Composite Index | 4,117.95 | 40.04 | -0.96% |